A presença de material de alto número atômico adjacente ao tecido mole aumenta localmente a dose absorvida pelo tecido quando submetido à radiação. Este efeito ocorre devido aos fotoelétrons ejetados do material de alto número atômico. Dosímetros de gel polimérico com partículas de ouro foram utilizados para investigar este efeito. Foram realizados cálculos analíticos para estimar o aumento de dose e simulações com o método de Monte Carlo. A irradiação de amostras de gel polimérico (GP) puro e com 0,005 gAu/gGP utilizando um feixe de raios X produzido por um potencial de 150 kV filtrado com 4 mmAl e 5 mmCu resultou em uma dose absorvida pelas amostras com ouro aproximadamente 20% maior que a dose absorvida pelas amostras de gel polimérico puro. Os cálculos analíticos e a simulação com o método de Monte Carlo resultaram em um aumento de aproximadamente 30% na dose absorvida. / The presence of high-Z material adjacent to soft tissue, when submitted to irradiation, enhances locally the absorbed dose in these soft tissues. Such effect occurs due to the outscattering of photoelectrons from the high-Z material. Polymer gel dosimeters have been used to investigate this effect. Analytic calculations to estimate the dose enhancement and Monte Carlo simulations have been performed. Samples containing polymer gel (PG) with 0.005 gAu/gPG and pure polymer gel have been irradiated using an X-rays beam produced by 150 kV, filtered with 4 mm Al and 5 mm Cu, which resulted in an approximately 20% higher absorbed dose in the samples with gold in comparison to those with pure polymer gel. The analytic calculations and the Monte Carlo simulation resulted in a dose enhancement factor of approximately 30%.

A presença de material de alto número atômico adjacente ao tecido mole aumenta localmente a dose absorvida pelo tecido quando submetido à radiação. Este efeito ocorre devido aos fotoelétrons ejetados do material de alto número atômico. Dosímetros de gel polimérico com partículas de ouro foram utilizados para investigar este efeito. Foram realizados cálculos analíticos para estimar o aumento de dose e simulações com o método de Monte Carlo. A irradiação de amostras de gel polimérico (GP) puro e com 0,005 gAu/gGP utilizando um feixe de raios X produzido por um potencial de 150 kV filtrado com 4 mmAl e 5 mmCu resultou em uma dose absorvida pelas amostras com ouro aproximadamente 20% maior que a dose absorvida pelas amostras de gel polimérico puro. Os cálculos analíticos e a simulação com o método de Monte Carlo resultaram em um aumento de aproximadamente 30% na dose absorvida. / The presence of high-Z material adjacent to soft tissue, when submitted to irradiation, enhances locally the absorbed dose in these soft tissues. Such effect occurs due to the outscattering of photoelectrons from the high-Z material. Polymer gel dosimeters have been used to investigate this effect. Analytic calculations to estimate the dose enhancement and Monte Carlo simulations have been performed. Samples containing polymer gel (PG) with 0.005 gAu/gPG and pure polymer gel have been irradiated using an X-rays beam produced by 150 kV, filtered with 4 mm Al and 5 mm Cu, which resulted in an approximately 20% higher absorbed dose in the samples with gold in comparison to those with pure polymer gel. The analytic calculations and the Monte Carlo simulation resulted in a dose enhancement factor of approximately 30%.

The goal of radiotherapy is to operate within the therapeutic window - delivering doses of ionizing radiation to achieve locoregional tumour control, while minimizing normal tissue toxicity. A greater therapeutic ratio can be achieved by utilizing radiosensitizing agents designed to enhance the effects of radiation at the tumour. Gold nanoparticles (AuNP) represent a novel radiosensitizer with unique and attractive properties. AuNPs enhance local photon interactions, thereby converting photons into localized damaging electrons. Experimental reports of AuNP radiosensitization reveal this enhancement effect to be highly sensitive to irradiation source energy, cell line, and AuNP size, concentration and intracellular localization. This thesis explored the physics and some of the underlying mechanisms behind AuNP radiosensitization. A Monte Carlo simulation approach was developed to investigate the enhanced photoelectric absorption within AuNPs, and to characterize the escaping energy and range of the photoelectric products. Simulations revealed a 10^3 fold increase in the rate of photoelectric absorption using low-energy brachytherapy sources compared to megavolt sources. For low-energy sources, AuNPs released electrons with ranges of only a few microns in the surrounding tissue. For higher energy sources, longer ranged photoelectric products travelled orders of magnitude farther. A novel radiobiological model called the AuNP radiosensitization predictive (ARP) model was developed based on the unique nanoscale energy deposition pattern around AuNPs. The ARP model incorporated detailed Monte Carlo simulations with experimentally determined parameters to predict AuNP radiosensitization. This model compared well to in vitro experiments involving two cancer cell lines (PC-3 and SK-BR-3), two AuNP sizes (5 and 30 nm) and two source energies (100 and 300 kVp). The ARP model was then used to explore the effects of AuNP intracellular localization using 1.9 and 100 nm AuNPs, and 100 and 300 kVp source energies. The impact of AuNP localization was most significant for low-energy sources. At equal mass concentrations, AuNP size did not impact radiosensitization unless the AuNPs were localized in the nucleus. This novel predictive model of AuNP radiosensitization could help define the optimal use of AuNPs in potential clinical strategies by determining therapeutic AuNP concentrations, and recommending when active approaches to cellular accumulation are most beneficial.

The goal of radiotherapy is to operate within the therapeutic window - delivering doses of ionizing radiation to achieve locoregional tumour control, while minimizing normal tissue toxicity. A greater therapeutic ratio can be achieved by utilizing radiosensitizing agents designed to enhance the effects of radiation at the tumour. Gold nanoparticles (AuNP) represent a novel radiosensitizer with unique and attractive properties. AuNPs enhance local photon interactions, thereby converting photons into localized damaging electrons. Experimental reports of AuNP radiosensitization reveal this enhancement effect to be highly sensitive to irradiation source energy, cell line, and AuNP size, concentration and intracellular localization. This thesis explored the physics and some of the underlying mechanisms behind AuNP radiosensitization. A Monte Carlo simulation approach was developed to investigate the enhanced photoelectric absorption within AuNPs, and to characterize the escaping energy and range of the photoelectric products. Simulations revealed a 10^3 fold increase in the rate of photoelectric absorption using low-energy brachytherapy sources compared to megavolt sources. For low-energy sources, AuNPs released electrons with ranges of only a few microns in the surrounding tissue. For higher energy sources, longer ranged photoelectric products travelled orders of magnitude farther. A novel radiobiological model called the AuNP radiosensitization predictive (ARP) model was developed based on the unique nanoscale energy deposition pattern around AuNPs. The ARP model incorporated detailed Monte Carlo simulations with experimentally determined parameters to predict AuNP radiosensitization. This model compared well to in vitro experiments involving two cancer cell lines (PC-3 and SK-BR-3), two AuNP sizes (5 and 30 nm) and two source energies (100 and 300 kVp). The ARP model was then used to explore the effects of AuNP intracellular localization using 1.9 and 100 nm AuNPs, and 100 and 300 kVp source energies. The impact of AuNP localization was most significant for low-energy sources. At equal mass concentrations, AuNP size did not impact radiosensitization unless the AuNPs were localized in the nucleus. This novel predictive model of AuNP radiosensitization could help define the optimal use of AuNPs in potential clinical strategies by determining therapeutic AuNP concentrations, and recommending when active approaches to cellular accumulation are most beneficial.

A incorporação de nanopartículas metálicas em tecidos tumorais tem sido estudada em Radioterapia devido ao aumento de dose que pode ser obtido no volume alvo do tratamento. Estudos indicam que nanopartículas de ouro (AuNP) estão entre as de maior viabilidade biológica para essas aplicações, devido ao baixo potencial tóxico. Além disso, estudos mostram que AuNP de alguns nanômetros até alguns micrômetros podem permear vasos sanguíneos que alimentam tumores, permitindo sua incorporação nas células tumorais. Desta forma, este trabalho visou estudar os fatores de aumento de dose obtidos em Radioterapia com AuNP incorporadas ao tecido tumoral utilizando feixes de ortovoltagem, de braquiterapia e de teleterapia. Este trabalho utilizou de uma metodologia computacional, através de simulação Monte Carlo com o código PENELOPE. Foram simulados feixes clínicos de 50, 80, 150 e 250 kVp, Ir-192 e 6 MV, e um modelo de célula tumoral com AuNPs incorporadas com diferentes concentrações de ouro. O modelo de células utilizado possui 13 µm de diâmetro externo máximo e 2 µm de diâmetro no núcleo. Dois modelos de incorporação de AuNPs foram implementados: modelo homogêneo e modelo heterogêneo. No modelo homogêneo, as AuNP foram distribuídas homogeneamente no núcleo e as células foram irradiadas nas diferentes energias estudadas para avaliar o fator de aumento de dose (DEF) em função da concentração de ouro na célula e da energia do feixe. No modelo heterogêneo, aglomerados de AuNPs foram simulados individualmente dentro da célula. Neste modelo foram utilizados somente os espetros de radiação que apresentaram os melhores desempenhos no modelo homogêneo. Foram avaliadas a fluência de partículas ejetadas nas AuNPs, o DEF, as distribuições de doses e os perfis de dose com aglomerados de 50 a 220 nm na célula. Os resultados obtidos para o modelo homogêneo mostram que os feixes de baixa energia são os que proporcionam maior DEF para uma mesma concentração de AuNP. Os maiores DEFs obtidos foram de 2,80; 2,99; 1,62 e 1,61, para os feixes de 50 kVp, 80 kVp, 150 kVp, 250 kVp, respectivamente, sendo a maior incerteza de 1,9% para o feixe de 250 kVp. Através dos resultados obtidos com o modelo heterogêneo foi possível concluir que os elétrons ejetados possuem maior influência no aumento local da dose. Os perfis de dose, extraídos das distribuições de doses, para os aglomerados simulados permitiram obter os alcances das isodoses de 50, 20 e 10% da dose no entorno das AuNPs. Através desses perfis de dose pode-se concluir que o aumento de dose é local, da ordem de alguns micrômetros, dependendo do tamanho das nanopartículas e da energia do feixe primário. Para o feixe de 50 kVp, o DEF encontrado para uma incorporação heterogênea de seis aglomerados de AuNPs, correspondendo a um modelo clínico real, foi de 1,79, com incerteza de 0,4%. Com base nos resultados obtidos pode-se concluir que as energias de ortovoltagem proporcionam maior fator de aumento de dose que feixes de megavoltagem utilizados em teleterapia convencional. Além disso, o reforço local de dose pode proporcionar um fator de radiossensibilização celular se as AuNPs forem incorporadas no núcleo das células, nas redondezas do DNA, proporcionando um maior potencial de controle tumoral. / The incorporation of metal nanoparticles into tumor tissues has been studied in radiation therapy given of the dose enhancement that can be obtained in the target volume of the treatment. Studies indicate that gold nanoparticles (AuNP) are among the highest biologically viable for such applications, due to their low toxic potential. In addition, studies show that AuNP from a few nanometers to a few micrometers can permeate blood vessels that feed tumors, allowing their incorporation into tumor cells. Hence, this study´s goal was to study the dose enhancement factors obtained in radiation therapy with AuNP incorporated in the tumor using orthovoltage, brachytherapy and teletherapy beams. This work used a computational methodology, through Monte Carlo simulation with the PENELOPE package. Clinical beams of 50, 80, 150 and 250 kVp, Ir-192 and 6 MV were simulated with a tumor cell model with incorporated AuNPs. The cell model has maximum outer diameter of 13 m and 2 m of nucleus diameter. Two models of AuNP incorporation were implemented: homogeneous model and heterogeneous model. In the homogeneous model the AuNP were distributed homogeneously in the nucleus and the cells were irradiated in the different beams studied to evaluate the dose enhancement factors (DEF) as a function of concentration of gold in the cell and radiation beam. In the heterogeneous model, clusters of AuNPs were simulated individually within the cell. In this model, the radiation spectra used was selected among those that presented the best performances in the homogeneous model. The fluence of particles ejected from the AuNPs, the DEFs, the dose distributions and dose profiles for clusters of 50 to 220 nm in the cell were evaluated. The results obtained for the homogeneous model show that lower energy beams provide the highest DEFs for the same concentration of AuNP. The highest DEFs obtained were 2.80; 2.99; 1.62 and 1.61, for the beams of 50 kVp, 80 kVp, 150 kVp, 250 kVp, respectively, with a maximun uncertainty of 1.9% for the 250 kVp beam. Through the results obtained with the heterogeneous model it was possible to conclude that the electrons ejected from he AuNPs have the major influence on the local dose enhancement. The dose profiles extracted from the dose distributions for the simulated clusters allowed the evaluation of the ranges for the 50, 20 and 10% isodoses in the surroundings of the AuNPs. Through these dose profiles, it can be concluded that the dose increase is local, in the order of a few micrometers, depending on the size of the nanoparticles and the energy of the primary beam. For the 50 kVp beam, the DEF found for a heterogeneous incorporation of six clusters of AuNPs, corresponding to an actual clinical model, was 1.79, with uncertainty of 0.4%. Based on the results obtained it can be concluded that kilovoltage energies provide a higher dose enhancement factor than megavoltage beams used in teletherapy. In addition, local dose enhancement may provide a cellular radiosensitization factor if the nanoparticles are incorporated in the nucleus of the cells, in the vicinity of the DNA, providing an enhanced potential for tumor control.

A incorporação de nanopartículas metálicas em tecidos tumorais tem sido estudada em Radioterapia devido ao aumento de dose que pode ser obtido no volume alvo do tratamento. Estudos indicam que nanopartículas de ouro (AuNP) estão entre as de maior viabilidade biológica para essas aplicações, devido ao baixo potencial tóxico. Além disso, estudos mostram que AuNP de alguns nanômetros até alguns micrômetros podem permear vasos sanguíneos que alimentam tumores, permitindo sua incorporação nas células tumorais. Desta forma, este trabalho visou estudar os fatores de aumento de dose obtidos em Radioterapia com AuNP incorporadas ao tecido tumoral utilizando feixes de ortovoltagem, de braquiterapia e de teleterapia. Este trabalho utilizou de uma metodologia computacional, através de simulação Monte Carlo com o código PENELOPE. Foram simulados feixes clínicos de 50, 80, 150 e 250 kVp, Ir-192 e 6 MV, e um modelo de célula tumoral com AuNPs incorporadas com diferentes concentrações de ouro. O modelo de células utilizado possui 13 µm de diâmetro externo máximo e 2 µm de diâmetro no núcleo. Dois modelos de incorporação de AuNPs foram implementados: modelo homogêneo e modelo heterogêneo. No modelo homogêneo, as AuNP foram distribuídas homogeneamente no núcleo e as células foram irradiadas nas diferentes energias estudadas para avaliar o fator de aumento de dose (DEF) em função da concentração de ouro na célula e da energia do feixe. No modelo heterogêneo, aglomerados de AuNPs foram simulados individualmente dentro da célula. Neste modelo foram utilizados somente os espetros de radiação que apresentaram os melhores desempenhos no modelo homogêneo. Foram avaliadas a fluência de partículas ejetadas nas AuNPs, o DEF, as distribuições de doses e os perfis de dose com aglomerados de 50 a 220 nm na célula. Os resultados obtidos para o modelo homogêneo mostram que os feixes de baixa energia são os que proporcionam maior DEF para uma mesma concentração de AuNP. Os maiores DEFs obtidos foram de 2,80; 2,99; 1,62 e 1,61, para os feixes de 50 kVp, 80 kVp, 150 kVp, 250 kVp, respectivamente, sendo a maior incerteza de 1,9% para o feixe de 250 kVp. Através dos resultados obtidos com o modelo heterogêneo foi possível concluir que os elétrons ejetados possuem maior influência no aumento local da dose. Os perfis de dose, extraídos das distribuições de doses, para os aglomerados simulados permitiram obter os alcances das isodoses de 50, 20 e 10% da dose no entorno das AuNPs. Através desses perfis de dose pode-se concluir que o aumento de dose é local, da ordem de alguns micrômetros, dependendo do tamanho das nanopartículas e da energia do feixe primário. Para o feixe de 50 kVp, o DEF encontrado para uma incorporação heterogênea de seis aglomerados de AuNPs, correspondendo a um modelo clínico real, foi de 1,79, com incerteza de 0,4%. Com base nos resultados obtidos pode-se concluir que as energias de ortovoltagem proporcionam maior fator de aumento de dose que feixes de megavoltagem utilizados em teleterapia convencional. Além disso, o reforço local de dose pode proporcionar um fator de radiossensibilização celular se as AuNPs forem incorporadas no núcleo das células, nas redondezas do DNA, proporcionando um maior potencial de controle tumoral. / The incorporation of metal nanoparticles into tumor tissues has been studied in radiation therapy given of the dose enhancement that can be obtained in the target volume of the treatment. Studies indicate that gold nanoparticles (AuNP) are among the highest biologically viable for such applications, due to their low toxic potential. In addition, studies show that AuNP from a few nanometers to a few micrometers can permeate blood vessels that feed tumors, allowing their incorporation into tumor cells. Hence, this study´s goal was to study the dose enhancement factors obtained in radiation therapy with AuNP incorporated in the tumor using orthovoltage, brachytherapy and teletherapy beams. This work used a computational methodology, through Monte Carlo simulation with the PENELOPE package. Clinical beams of 50, 80, 150 and 250 kVp, Ir-192 and 6 MV were simulated with a tumor cell model with incorporated AuNPs. The cell model has maximum outer diameter of 13 m and 2 m of nucleus diameter. Two models of AuNP incorporation were implemented: homogeneous model and heterogeneous model. In the homogeneous model the AuNP were distributed homogeneously in the nucleus and the cells were irradiated in the different beams studied to evaluate the dose enhancement factors (DEF) as a function of concentration of gold in the cell and radiation beam. In the heterogeneous model, clusters of AuNPs were simulated individually within the cell. In this model, the radiation spectra used was selected among those that presented the best performances in the homogeneous model. The fluence of particles ejected from the AuNPs, the DEFs, the dose distributions and dose profiles for clusters of 50 to 220 nm in the cell were evaluated. The results obtained for the homogeneous model show that lower energy beams provide the highest DEFs for the same concentration of AuNP. The highest DEFs obtained were 2.80; 2.99; 1.62 and 1.61, for the beams of 50 kVp, 80 kVp, 150 kVp, 250 kVp, respectively, with a maximun uncertainty of 1.9% for the 250 kVp beam. Through the results obtained with the heterogeneous model it was possible to conclude that the electrons ejected from he AuNPs have the major influence on the local dose enhancement. The dose profiles extracted from the dose distributions for the simulated clusters allowed the evaluation of the ranges for the 50, 20 and 10% isodoses in the surroundings of the AuNPs. Through these dose profiles, it can be concluded that the dose increase is local, in the order of a few micrometers, depending on the size of the nanoparticles and the energy of the primary beam. For the 50 kVp beam, the DEF found for a heterogeneous incorporation of six clusters of AuNPs, corresponding to an actual clinical model, was 1.79, with uncertainty of 0.4%. Based on the results obtained it can be concluded that kilovoltage energies provide a higher dose enhancement factor than megavoltage beams used in teletherapy. In addition, local dose enhancement may provide a cellular radiosensitization factor if the nanoparticles are incorporated in the nucleus of the cells, in the vicinity of the DNA, providing an enhanced potential for tumor control.

Gold nanoparticles (GNPs) have recently attracted considerable interest for use in radiation therapy due to their unique physical and biological properties. Of interest, GNPs (and other high-atomic-number materials) have been used to enhance radiation dose in tumors by taking advantage of increased photoelectric absorption. This physical phenomenon is well-understood on a macroscopic scale. However, biological outcomes often depend on the intratumoral and even intracellular distribution of GNPs, among other factors. Therefore, there exists a need to precisely visualize and accurately quantify GNP distributions. By virtue of the photoelectric effect, x-ray fluorescence (XRF) photons (characteristic x-rays) from gold can be induced and detected, not only allowing the distribution of GNPs within biological samples to be determined but also providing a unique molecular imaging option in conjunction with bioconjugated GNPs. This work proposes the use of this imaging modality, known as XRF imaging, to develop experimental imaging techniques for detecting and quantifying sparse distributions of GNPs in preclinical settings, such as within small-animal-sized objects, tissue samples, and superficial tumors. By imaging realistic GNP distributions, computational methods can then be used to understand radiation dose enhancement on an intratumoral scale and perhaps even down to the nanoscopic, subcellular realm, elucidating observed biological outcomes (e.g., radiosensitization of tumors) from the bottom-up. Ultimately, this work will result in experimental and computational tools for developing a better understanding of GNP-mediated dose enhancement and associated radiosensitization within the scope of GNP-aided radiation therapy.

Cancer is one of the leading causes of death worldwide, and affects roughly 1.5 million new people in the United States every year. One of the leading tools in the detection and treatment of cancer is radiation. Tumors can be detected and identified using CT or PET scans, and can then be treated with external beam radiotherapy or brachytherapy. By taking advantage of the physical properties of gold and the biological properties of nanoparticles, gold nanoparticles (GNPs) can be used to improve both cancer radiotherapy and imaging. By infusing a tumor with GNPs, either using passive extravasation of nanoparticles by the tumor vasculature or active targeting of an antibody-conjugated nanoparticle to a specific tumor marker, the higher photon cross-section of gold will cause more radiation dose to be deposited in the tumor during photon-based radiotherapy. In principle, this would allow escalation of dose to the tumor while not increasing the dose to normal healthy tissue. Additionally, if a tumor infused with GNPs was irradiated by an external kilo-voltage source, the fluorescence emitted by the gold atoms would allow one to localize and quantify the GNP concentration. This work has two main aims: to quantify the GNP-mediated dose enhancement during GNRT on a nanometer scale, and to develop a refined imaging modality capable of quantifying GNP location and concentration within a small-animal-sized object. In order to quantify the GNP-mediated dose enhancement on a nanometer scale, a computational model was developed. This model combines both large-scale and small-scale calculations in order to accurately determine the heterogeneous dose distribution of GNPs. The secondary electron spectra were calculated using condensed history Monte Carlo, which is able to accurately take into account changes in beam quality throughout the tumor and calculate the average energy spectrum of the secondary charged particles created. Then, the dose distributions of these electron spectra were calculated on a nanometer scale using event-by-event Monte Carlo. The second aim is to develop an imaging system capable of reconstructing a tomographic image of GNP location and concentration in a small animal-sized object by capturing gold fluorescence photons emitted during irradiation of the object by an external beam. This would not only allow for localization of GNPs during gold nanoparticle-aided radiation therapy (GNRT), but also facilitate the use of GNPs as imaging agents for drug-delivery or other similar studies. The purpose of this study is to develop a cone-beam implementation of XFCT that meets realistic constrains on image resolution, detection limit, scan time, and dose. A Monte Carlo model of this imaging geometry was developed and used to test the methods of data acquisition and image reconstruction. The results of this study were then used to drive the production of a functioning benchtop, polychromatic cone-beam XFCT system.